Anavex Life Sciences
AVXL
#8655
Rank
NZ$0.39 B
Marketcap
NZ$4.31
Share price
-2.36%
Change (1 day)
-76.64%
Change (1 year)

Revenue for Anavex Life Sciences (AVXL)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Anavex Life Sciences from 2009 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.47 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.33 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$22.32 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.53 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA